ATE244578T1 - Behandlung eines durch helicobakter verursachten gastroduodenalen krankheit - Google Patents

Behandlung eines durch helicobakter verursachten gastroduodenalen krankheit

Info

Publication number
ATE244578T1
ATE244578T1 AT94922799T AT94922799T ATE244578T1 AT E244578 T1 ATE244578 T1 AT E244578T1 AT 94922799 T AT94922799 T AT 94922799T AT 94922799 T AT94922799 T AT 94922799T AT E244578 T1 ATE244578 T1 AT E244578T1
Authority
AT
Austria
Prior art keywords
treatment
helicobacter
disease caused
gastroduodenal disease
heliobacter
Prior art date
Application number
AT94922799T
Other languages
English (en)
Inventor
Christopher Vincent Doidge
Adrian Lee
Original Assignee
Csl Ltd
Univ New South Wales
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25644506&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE244578(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from AUPM3828A external-priority patent/AUPM382894A0/en
Application filed by Csl Ltd, Univ New South Wales filed Critical Csl Ltd
Application granted granted Critical
Publication of ATE244578T1 publication Critical patent/ATE244578T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT94922799T 1993-07-27 1994-07-25 Behandlung eines durch helicobakter verursachten gastroduodenalen krankheit ATE244578T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPM015793 1993-07-27
AUPM3828A AUPM382894A0 (en) 1994-02-14 1994-02-14 Treatment of H.pylori associated gastroduodenal disease
PCT/AU1994/000416 WO1995003824A1 (en) 1993-07-27 1994-07-25 Treatment of h. pylori associated gastroduodenal disease

Publications (1)

Publication Number Publication Date
ATE244578T1 true ATE244578T1 (de) 2003-07-15

Family

ID=25644506

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94922799T ATE244578T1 (de) 1993-07-27 1994-07-25 Behandlung eines durch helicobakter verursachten gastroduodenalen krankheit

Country Status (10)

Country Link
US (2) US5871749A (de)
EP (1) EP0716613B1 (de)
JP (1) JP3919812B2 (de)
KR (1) KR100333113B1 (de)
AT (1) ATE244578T1 (de)
CA (1) CA2154063C (de)
DE (1) DE69432929T2 (de)
HK (1) HK1005541A1 (de)
NZ (2) NZ269124A (de)
WO (1) WO1995003824A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141244B1 (en) * 1992-03-02 2006-11-28 Chiron Srl Helicobacter pylori proteins useful for vaccines and diagnostics
US6290962B1 (en) 1992-11-03 2001-09-18 Oravax, Inc. Urease-based vaccine and treatment for helicobacter infection
WO1995014093A1 (en) 1993-05-19 1995-05-26 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides
US5843460A (en) * 1993-05-19 1998-12-01 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides
US6406703B1 (en) * 1993-07-27 2002-06-18 Csl Limited Treatment of H. pylori associated gastroduodenal disease
GB9326174D0 (en) * 1993-12-22 1994-02-23 Biocine Sclavo Mucosal adjuvant
AUPM399594A0 (en) * 1994-02-21 1994-03-17 Csl Limited Antigenic preparation for treatment or prevention of helicobacter infection
AUPM612494A0 (en) * 1994-06-08 1994-06-30 Csl Limited Treatment or prevention of helicobacter infection
EP0769018B1 (de) * 1994-07-01 2002-12-18 Chiron Corporation Helicobacter proteine und impstoffe
CZ104297A3 (en) * 1994-10-05 1997-11-12 Microcarb Methods of producing higher antigenic heliobacter spp. and vaccines containing thereof
US5679564A (en) * 1994-10-05 1997-10-21 Antex Biologics, Inc. Methods for producing enhanced antigenic campylobacter bacteria and vaccines
FR2732605B1 (fr) * 1995-04-07 1997-05-16 Pasteur Merieux Serums Vacc Composition destinee a l'induction d'une reponse immunitaire mucosale
KR19990007828A (ko) * 1995-04-21 1999-01-25 피터 터비 헬리코박터 감염 방어 항원
PT909323E (pt) * 1996-01-04 2007-06-04 Novartis Vaccines & Diagnostic ''bacterioferritina de helicobacter pilori''
US6818222B1 (en) 1997-03-21 2004-11-16 Chiron Corporation Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
US6599509B2 (en) * 1997-09-02 2003-07-29 Massachusetts Institute Of Technology Compositions and methods comprising helicobacter antigens for treatment and prevention of inflammatory bowel disease
AU770498B2 (en) * 1998-06-19 2004-02-26 Merieux Oravax LT and CT in parenteral immunization methods against helicobacter infection
US20020107368A1 (en) * 2000-12-07 2002-08-08 Jing-Hui Tian Helicobacter proteins, gene sequences and uses thereof
US20020177614A1 (en) * 2001-03-23 2002-11-28 Merril Carl R. Methods for treating nuerodegenerative diseases including alzheimer's
JP2005506322A (ja) * 2001-08-31 2005-03-03 カイロン ソチエタ ア レスポンサビリタ リミタータ Ｈｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉワクチン接種

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459041A (en) * 1988-02-18 1995-10-17 Enteric Research Laboratories, Inc. Campylobacter pylori antigens and uses thereof for detection of Campylobacter pylori infection
FR2637612B1 (fr) * 1988-10-06 1993-09-10 Pasteur Institut Sequences de nucleotides codant pour une proteine a activite ureasique
DE4139840B4 (de) * 1990-12-04 2005-06-02 Quidel Corp., San Diego Antigen-Zubereitung zum Nachweis von H. pylori
CA2109088A1 (en) * 1991-04-26 1992-10-27 Emanuel Calenoff Methods to detect and treat diseases caused by bacterial allergens
US5370872A (en) * 1991-08-12 1994-12-06 Swiss Serum And Vaccine Institute Berne Escherichia coliO-polysaccharide-protein conjugate vaccine
FR2682122B1 (fr) * 1991-10-03 1995-06-09 Pasteur Institut Nouveaux genes d'helicobacter pylori. leur utilisation pour la preparation de souches recombinantes de h. pylori.
DE69333585T2 (de) * 1992-02-26 2005-07-28 Vanderbilt University, Nashville Gereinigtes vakuolisierendes toxin aus helicobacter pylori und methoden zu dessen verwendung
EP0967279B1 (de) * 1992-03-02 2008-01-02 Novartis Vaccines and Diagnostics S.r.l. Helicobacter pylori Cytotoxin verwendbar in Impfstoffe und Diagnostik
MX9301706A (es) * 1992-04-13 1994-05-31 Oravax Inc Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
US5370873A (en) * 1992-09-11 1994-12-06 Udeinya; Iroka J. Therapeutic compounds derived from the neem tree
US5403924A (en) * 1992-10-13 1995-04-04 Vanderbilt University Taga gene and methods for detecting predisposition to peptic ulceration
US5972336A (en) * 1992-11-03 1999-10-26 Oravax Merieux Co. Urease-based vaccine against helicobacter infection
US6290962B1 (en) * 1992-11-03 2001-09-18 Oravax, Inc. Urease-based vaccine and treatment for helicobacter infection
AR003125A1 (es) * 1995-06-01 1998-07-08 Astra Ab Antigenos bacterianos para el diagnostico de infecciones con helicobacter pylori, una molecula de adn que lo codifica, un vector, una celula huesped,procedimiento para producir el polipeptido, composiciones para vacunas adecuadas para uso terapeutico y profilactico, el uso del polipeptido en la
BR9712587A (pt) * 1996-10-28 1999-10-26 Astra Ab ‡cido nucléico, molécula de ácido nucléico, sonda, vetor de expressão recombinante, célula, processos para produzir um polipeptìdeo de h. pylori e para detectar a presença de um ácido nucléico de helicobacter pylori em uma amostra, polipeptìdeo de h. pylori isolado, polipeptìdeos de envelope de célula, celular e secretado de h. pylori ou seus fragmentos, proteìna de fusão, formulação de vacina para a profilaxia ou tratamento de uma infecção por h. pylori, e, processos para tratar ou reduzir um risco de infecção por h. pylori em um sujeito e para produzir uma formulação de vacina.

Also Published As

Publication number Publication date
EP0716613B1 (de) 2003-07-09
US5871749A (en) 1999-02-16
AU679542B2 (en) 1997-07-03
US6129923A (en) 2000-10-10
JPH09500651A (ja) 1997-01-21
CA2154063C (en) 2006-11-21
KR960700746A (ko) 1996-02-24
HK1005541A1 (en) 1999-01-15
WO1995003824A1 (en) 1995-02-09
EP0716613A1 (de) 1996-06-19
JP3919812B2 (ja) 2007-05-30
CA2154063A1 (en) 1995-02-09
NZ314585A (en) 2000-08-25
DE69432929T2 (de) 2004-04-15
DE69432929D1 (de) 2003-08-14
KR100333113B1 (ko) 2002-11-27
AU7260694A (en) 1995-02-28
EP0716613A4 (de) 1998-05-20
NZ269124A (en) 1997-06-24

Similar Documents

Publication Publication Date Title
ATE244578T1 (de) Behandlung eines durch helicobakter verursachten gastroduodenalen krankheit
MX9301706A (es) Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
NO942490D0 (no) Urease-basert vaksine mot Heliobacter-infeksjon
NO963508L (no) Urease-basert vaksine og behandling av Helicobacter-infeksjon
DK1296711T3 (da) HPV-E7 til behandling af humant papillomavirus
NO932102L (no) Oligosakkarid avledet fra antigent polysakkarid erholdt fra et patogen
DE69527986D1 (de) Antigene arznei zur behandlung oder vorbeugung
HUP9901958A2 (hu) Sertés reproduktív és respirációs szindróma vakcina
SE8105079L (sv) Antibiotikum bmg162-af2
DK16087D0 (da) Mastitis-vaccine
EP0090660A3 (de) Neisseria Gonorrhöe Vakzin
DK0485463T3 (da) Svækket hundeparvovirus (CPV), vaccine omfattende CPV og fremgangsmåde til forebyggelse af CPV-infektion i hunde
DK0809653T3 (da) Helicobacter pylori-antigen
ATE39055T1 (de) Verfahren zur immunisierung von schweinen gegen die aujeszky-krankheit.
NO934547L (no) Oral behandling av Helicobacter-infeksjon
JPS562918A (en) Preventive and remedy for infection of pig atrophic rhinitis
RU2001106308A (ru) Способ лечения гнойных инфекций

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties